SC Pharmaceuticals Inc (NQ: SCPH )
Price and Volume
Detailed Quote| Volume | 81,181 |
| Open | 4.340 |
| Bid (Size) | 4.000 (2) |
| Ask (Size) | 4.490 (1) |
| Prev. Close | 4.370 |
| Today's Range | 4.160 - 4.340 |
| 52wk Range | 3.240 - 9.230 |
| Shares Outstanding | 35,769,073 |
| Dividend Yield | N/A |
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 05, 2024
Performance
More News
Read More
Recap: scPharmaceuticals Q4 Earnings
March 13, 2024
A Preview Of scPharmaceuticals's Earnings
March 12, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 22, 2024
Recap: scPharmaceuticals Q3 Earnings
November 08, 2023
Earnings Preview: scPharmaceuticals
November 07, 2023
Earnings Outlook For scPharmaceuticals
August 09, 2023
The Latest Analyst Ratings for scPharmaceuticals
July 19, 2023
Analyst Ratings for scPharmaceuticals
June 08, 2023
Earnings Scheduled For March 13, 2024
March 13, 2024
Dow Up 150 Points; Gold Jumps Over 2%
March 23, 2023
Earnings Preview For scPharmaceuticals
March 21, 2023
What 4 Analyst Ratings Have To Say About scPharmaceuticals
January 27, 2023
Expert Ratings for scPharmaceuticals
December 01, 2022
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Earnings Scheduled For August 10, 2023
August 10, 2023
Earnings Outlook For scPharmaceuticals
May 09, 2023
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
March 23, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
February 27, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
February 17, 2023
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.